JPMorgan Chase & Co. Cuts Victrex (LON:VCT) Price Target to GBX 625

Victrex (LON:VCT) had its price objective lowered by JPMorgan Chase & Co. from GBX 725 to GBX 625 in a report published on Wednesday morning, Marketbeat.com reports. JPMorgan Chase & Co. currently has a buy rating on the stock.

Separately, Deutsche Bank Aktiengesellschaft decreased their target price on Victrex from GBX 850 to GBX 780 and set a “hold” rating for the company in a research report on Tuesday, December 2nd. One equities research analyst has rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of GBX 756.25.

Victrex Stock Down 0.9%

Shares of Victrex stock opened at GBX 539 on Wednesday. The business has a 50-day moving average price of GBX 673.55 and a 200 day moving average price of GBX 667.19. Victrex has a fifty-two week low of GBX 534 and a fifty-two week high of GBX 969. The firm has a market cap of £469.32 million, a P/E ratio of 16.95, a P/E/G ratio of 1.92 and a beta of 0.65. The company has a quick ratio of 1.99, a current ratio of 3.01 and a debt-to-equity ratio of 11.30.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.